You are here
Chugai investing S$476m more into S'pore facility
JAPANESE drug maker Chugai Pharmaceutical on Wednesday announced that it will invest S$476 million from now until 2021 into its research institute in Singapore, Chugai Pharmabody Research (CPR).
When CPR first set up its corporate laboratory here in 2012 to develop
- CALL +65 6388 3838
- EMAIL email@example.com